FY2026 · period end Mar '26 · from the 10-K filed May 29, 2026
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Revenue | $5.94B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-K | 0001628280-26-039136 | Mar 31, 2026 | May 29, 2026 | May 29, 2026 20:04 UTC | EDGAR |
| 8-K | 0001628280-26-033580 | May 11, 2026 | May 11, 2026 | May 11, 2026 20:34 UTC | EDGAR |
| 8-K | 0001193125-26-212159 | May 1, 2026 | May 7, 2026 | May 7, 2026 20:35 UTC | EDGAR |
| 8-K | 0001193125-26-143973 | Mar 31, 2026 | Apr 6, 2026 | Apr 6, 2026 21:02 UTC | EDGAR |
| 10-Q | 0001628280-26-006055 | Dec 31, 2025 | Feb 6, 2026 | Feb 6, 2026 21:04 UTC | EDGAR |
| 8-K | 0001628280-26-005473 | Feb 4, 2026 | Feb 4, 2026 | Feb 4, 2026 21:32 UTC | EDGAR |
| 10-Q | 0001628280-25-050160 | Sep 30, 2025 | Nov 6, 2025 | Nov 6, 2025 21:08 UTC | EDGAR |
| 8-K | 0001757898-25-000011 | Nov 5, 2025 | Nov 5, 2025 | Nov 5, 2025 21:41 UTC | EDGAR |
Direct links to SEC EDGAR. STE has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2023
Major restatementwas$157.3M
Revised up in a 10-K.
Operating Income (Loss)·FY 2023
Major restatementwas$268.2M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2022
Major restatementwas$314.5M
Revised up in a 10-K.
Operating Income (Loss)·FY 2022
Major restatementwas$425.6M
Revised up in a 10-K.
Gross Profit·Q2 2022
Notable restatementwas$532.3M
Revised down in a 10-K.
Revenues·Q2 2022
Notable restatementwas$1.2B
Revised down in a 10-K. Any P/S built on the original was 10.0% too low.
STE is not the only one.
See every restatement we've found across the market — or get an alert the next time STE revises a number.
Restatements are detected by comparing every vintage of a fact across all of STERIS plc's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows STE's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling STERIS plc — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on STE yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on STE and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $5.14B |
| $4.54B |
| $4.22B |
| Gross Profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B |
|---|
| Operating Income | $1.10B | $0.87B | $0.84B | $0.79B | $0.48B |
|---|
| Net Income | $0.78B | $0.61B | $0.38B | $0.11B | $0.24B |
|---|
| EPS (Diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
|---|
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Total Assets | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B |
| Total Liabilities | $3.54B | $3.53B | $4.75B | $4.73B | $4.88B |
| Stockholders' Equity | $7.20B | $6.62B | $6.32B | $6.09B | $6.54B |
| Cash & Equivalents | $0.44B | $0.17B | $0.21B | $0.21B | $0.35B |
| Total Debt | — | — | — | — | — |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.34B | $1.15B | $0.97B | $0.76B | $0.68B |
| Capital Expenditures | $0.37B | $0.37B | $0.36B | $0.36B | $0.29B |
| Free Cash Flow | $0.97B | $0.78B | $0.61B | $0.39B | $0.40B |
| Metric | FY26Mar '26 | FY25Mar '25 | FY24Mar '24 | FY23Mar '23 | FY22Mar '22 |
|---|---|---|---|---|---|
| Gross Margin | 44.2% | 44.0% | 43.2% | 43.7% | 44.6% |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% |
| Return on Equity | 11.3% | 9.5% | 6.1% | 1.7% | 4.7% |
| Return on Assets | 7.5% | 5.8% | 3.5% | 1.0% | 2.7% |
| Debt / Equity | 0.27× | 0.31× | 0.51× | 0.51× | 0.47× |
